{"date_created":"2011-01-25","rcv_accession_id":"RCV000013444","record_status":"current","interpretation_description":"Pathogenic","submitter_id":"3","clinical_assertion_observation_ids":["SCV000033691.0"],"variation_id":"12610","interpretation_date_last_evaluated":"2008-03-15","submission_id":"3.2010-12-30","clinical_assertion_trait_set_id":"SCV000033691","interpretation_comments":[],"local_key":"190020.0011_COSTELLO SYNDROME","id":"SCV000033691","variation_archive_id":"VCV000012610","internal_id":"33691","version":"2","title":"HRAS, THR58ILE_COSTELLO SYNDROME","date_last_updated":"2019-03-31","assertion_type":"variation to disease","trait_set_id":"3420","review_status":"no assertion criteria provided","submission_names":[]}
{"date_created":"2017-12-15","rcv_accession_id":"RCV000013444","record_status":"current","interpretation_description":"Pathogenic","submitter_id":"506439","clinical_assertion_observation_ids":["SCV000616365.0"],"variation_id":"12610","submitted_assembly":"GRCh38","interpretation_date_last_evaluated":"2017-04-03","submission_id":"506439.2019-02-25","clinical_assertion_trait_set_id":"SCV000616365","interpretation_comments":["{\"text\":\"The c.173C\u003eT (p.Thr58Ile) variant in HRAS has been reported in the literature as an unconfirmed de novo occurrence in a patient with clinical features of a RASopathy (PM6; PMID 20112233, 16474405). Also, at least 2 independent occurrences of this variant have been detected in patients with a RASopathy (PS4_Supporting; PMID: 22488832, 18247425, 23321623, 20949621, 16921267). This variant was absent from large population studies (PM2; ExAC, http://exac.broadinstitute.org). The p.Thr58Ile variant in HRAS is analogous to the same previously established amino acid change in the KRAS gene and the ClinGen RASopathy Expert Panel has defined that the pathogenicities of analogous variants in the HRAS and KRAS genes are correlated based on the assumption that a known functional residue in one gene is equivalent to other functions within that subgroup (PS1; 29493581). Furthermore, the variant is in a location that has been defined by the ClinGen RASopathy Expert Panel to be a mutational hotspot or domain of HRAS (PM1; PMID 29493581). The variant is in HRAS, which has been defined by the ClinGen RASopathy Expert Panel as a gene with low rate of benign missense with missense variants commonly being pathogenic (PP2; PMID 29493581). Computational prediction tools and conservation analysis suggest that the p.Thr58Ile variant may impact the protein (PP3). In summary, this variant meets criteria to be classified as pathogenic for RASopathies in an autosomal dominant manner. Rasopathy-specific ACMG/AMP criteria applied (PMID:29493581): PM6, PS4_Supporting, PM2, PS1, PM1, PP2, PP3.\",\"type\":\"public\"}"],"content":"{\"@FDARecognizedDatabase\":\"true\",\"AttributeSet\":[{\"Attribute\":{\"$\":\"Autosomal dominant inheritance\",\"@Type\":\"ModeOfInheritance\"}},{\"Attribute\":{\"$\":\"ClinGen RASopathy ACMG Specifications v1\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"URL\":{\"$\":\"https://submit.ncbi.nlm.nih.gov/ft/byid/60rptlbs/clingen_rasopathy_acmg_specifications_v1.pdf\"}}}],\"Interpretation\":{\"Citation\":[{\"ID\":{\"$\":\"20949621\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"16474405\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"20112233\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"16921267\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"22488832\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"23321623\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"18247425\",\"@Source\":\"PubMed\"}},{\"URL\":{\"$\":\"https://erepo.clinicalgenome.org/evrepo/ui/interpretation/4fa14d9d-3bce-4dd8-affa-771b6298c4fc\"}}]}}","local_key":"4fa14d9d-3bce-4dd8-affa-771b6298c4fc|Orphanet:ORPHA3071","id":"SCV000616365","variation_archive_id":"VCV000012610","internal_id":"1202773","version":"3","date_last_updated":"2019-03-31","assertion_type":"variation to disease","trait_set_id":"3420","review_status":"reviewed by expert panel","submission_names":["SUB5222244"]}
{"date_created":"2013-03-16","rcv_accession_id":"RCV000013444","record_status":"current","interpretation_description":"Pathogenic","submitter_id":"21766","clinical_assertion_observation_ids":["SCV000062127.0"],"variation_id":"12610","submitted_assembly":"GRCh37","interpretation_date_last_evaluated":"2014-09-23","submission_id":"21766.2018-02-23","clinical_assertion_trait_set_id":"SCV000062127","interpretation_comments":["{\"text\":\"The Thr58Ile variant in HRAS has been reported in three individuals with clinical features of Costello syndrome (Gripp 2008, Gripp 2012, LMM unpublished data). It was identified to occur de novo in two of these individuals and segregated with disease in one affected relative from one of these families. This variant was absent from large population studies. Computational prediction tools and conservation analysis suggest that this variant may impact the protein, though this information is not predictive enough to determine pathogenicity. In summary, this variant meets our criteria to be classified as pathogenic (http://pcpgm.partners.org/LMM).\",\"type\":\"public\"}"],"content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"LMM Criteria\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"ID\":{\"$\":\"24033266\",\"@Source\":\"PubMed\"}}},\"Interpretation\":{\"Citation\":[{\"ID\":{\"$\":\"22488832\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"18247425\",\"@Source\":\"PubMed\"}}]}}","local_key":"26351883|OMIM:218040","id":"SCV000062127","variation_archive_id":"VCV000012610","internal_id":"103327","version":"5","date_last_updated":"2019-03-31","assertion_type":"variation to disease","trait_set_id":"3420","review_status":"criteria provided, single submitter","submission_names":["SUB3719835"]}
{"date_created":"2013-11-19","rcv_accession_id":"RCV000003697","record_status":"current","interpretation_description":"Pathogenic","submitter_id":"256489","clinical_assertion_observation_ids":["SCV000106043.0"],"variation_id":"3520","submitted_assembly":"not applicable","submission_id":"256489.2017-03-08","clinical_assertion_trait_set_id":"SCV000106043","interpretation_comments":[],"local_key":"NM_005957.4:c.665C\u003eT|MedGen:C1856059","id":"SCV000106043","variation_archive_id":"VCV000003520","internal_id":"183447","version":"1","date_last_updated":"2019-03-31","assertion_type":"variation to disease","trait_set_id":"916","review_status":"no assertion criteria provided","submission_names":["FirmaLab_clinical_tests_from_GTR"]}
{"date_created":"2014-11-11","rcv_accession_id":"RCV000144921","record_status":"current","interpretation_description":"Uncertain significance","submitter_id":"505267","clinical_assertion_observation_ids":["SCV000187678.0"],"variation_id":"3520","submission_id":"505267.2014-07-16","clinical_assertion_trait_set_id":"SCV000187678","interpretation_comments":[],"content":"{\"Citation\":[{\"@Type\":\"general\",\"ID\":{\"$\":\"25227144\",\"@Source\":\"PubMed\"}},{\"@Type\":\"general\",\"ID\":{\"$\":\"25227144\",\"@Source\":\"PubMed\"}}],\"Interpretation\":{\"Citation\":{\"@Type\":\"general\",\"ID\":{\"$\":\"25227144\",\"@Source\":\"PubMed\"}}}}","local_key":"rs1801133","id":"SCV000187678","variation_archive_id":"VCV000003520","internal_id":"339358","version":"1","date_last_updated":"2019-03-31","assertion_type":"variation to disease","trait_set_id":"6607","review_status":"no assertion criteria provided","submission_names":[]}
{"date_created":"2017-03-02","rcv_accession_id":"RCV000427078","record_status":"current","interpretation_description":"not provided","submitter_id":"505871","clinical_assertion_observation_ids":["SCV000505736.0"],"variation_id":"3520","submitted_assembly":"GRCh37","interpretation_date_last_evaluated":"2016-03-10","submission_id":"505871.2016-07-18","clinical_assertion_trait_set_id":"SCV000505736","interpretation_comments":[],"content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"Somatic mutation\",\"@Type\":\"ModeOfInheritance\"}},\"Citation\":{\"URL\":{\"$\":\"http://docm.genome.wustl.edu/variants/ENST00000376592:c.665C\u003eT\"}},\"Interpretation\":{\"Citation\":{\"ID\":{\"$\":\"18704422\",\"@Source\":\"PubMed\"}}},\"StudyDescription\":{\"$\":\"This is the initial submission of DoCM to ClinVar. DoCM is the database of curated mutations in cancer and seeks to leverage the community to outline all functionally important somatic cancer variants in the literature.\"}}","local_key":"ENST00000376592:c.665C\u003eT|MeSH:D013274","id":"SCV000505736","variation_archive_id":"VCV000003520","internal_id":"971011","version":"1","date_last_updated":"2019-03-31","assertion_type":"variation to disease","trait_set_id":"6728","review_status":"no assertion provided","submission_names":["DoCM_7-13-16"]}
{"date_created":"2016-12-02","rcv_accession_id":"RCV000259890","record_status":"current","interpretation_description":"Likely benign","submitter_id":"504895","clinical_assertion_observation_ids":["SCV000347807.0"],"variation_id":"3520","submitted_assembly":"GRCh37","interpretation_date_last_evaluated":"2016-06-14","submission_id":"504895.2016-10-18","clinical_assertion_trait_set_id":"SCV000347807","interpretation_comments":[],"content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"ICSL Variant Classification 20161018\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"@Type\":\"general\",\"CitationText\":{\"$\":\"ICSL_Variant_Classification_20161018.pdf\"},\"URL\":{\"$\":\"https://submit.ncbi.nlm.nih.gov/ft/byid/4jQgNGYk/ICSL_Variant_Classification_20161018.pdf\"}}}}","local_key":"361|Neural Tube Defects, Folate-Sensitive","id":"SCV000347807","variation_archive_id":"VCV000003520","internal_id":"661330","version":"2","date_last_updated":"2019-03-31","assertion_type":"variation to disease","trait_set_id":"6564","review_status":"criteria provided, single submitter","submission_names":["ICSL_2016Q4"]}
{"date_created":"2016-05-18","rcv_accession_id":"RCV000211336","record_status":"current","interpretation_description":"drug response","submitter_id":"500295","clinical_assertion_observation_ids":["SCV000268238.0"],"variation_id":"3520","submitted_assembly":"GRCh38","interpretation_date_last_evaluated":"2016-07-11","submission_id":"500295.2018-06-18","clinical_assertion_trait_set_id":"SCV000268238","interpretation_comments":["{\"text\":\"PharmGKB Level of Evidence 2A: Annotation for a variant-drug combination that qualifies for level 2B where the variant is within a VIP (Very Important Pharmacogene) as defined by PharmGKB. The variants in level 2A are in known pharmacogenes, so functional significance is more likely.\",\"type\":\"public\"}"],"content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"Pharmacogenomics knowledge for personalized medicine\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"ID\":{\"$\":\"22992668\",\"@Source\":\"PubMed\"}}},\"Citation\":{\"URL\":{\"$\":\"https://www.pharmgkb.org/clinicalAnnotation/981220481\"}},\"Comment\":{\"$\":\"Drug is not necessarily used to treat response condition\",\"@Type\":\"public\"},\"Interpretation\":{\"Citation\":[{\"ID\":{\"$\":\"19307503\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"21605004\",\"@Source\":\"PubMed\"}}],\"ExplanationOfInterpretation\":{\"$\":\"Drug-variant association: Efficacy\"}}}","local_key":"981220481PA448803|carboplatin response - Efficacy","id":"SCV000268238","variation_archive_id":"VCV000003520","internal_id":"503705","version":"3","date_last_updated":"2019-03-31","assertion_type":"variation to disease","trait_set_id":"26870","review_status":"reviewed by expert panel","submission_names":["PharmGKB-ClinVar 2018-05"]}
{"date_created":"2016-05-18","rcv_accession_id":"RCV000211133","record_status":"current","interpretation_description":"drug response","submitter_id":"500295","clinical_assertion_observation_ids":["SCV000268236.0"],"variation_id":"3520","submitted_assembly":"GRCh38","interpretation_date_last_evaluated":"2016-07-11","submission_id":"500295.2018-06-18","clinical_assertion_trait_set_id":"SCV000268236","interpretation_comments":["{\"text\":\"PharmGKB Level of Evidence 2A: Annotation for a variant-drug combination that qualifies for level 2B where the variant is within a VIP (Very Important Pharmacogene) as defined by PharmGKB. The variants in level 2A are in known pharmacogenes, so functional significance is more likely.\",\"type\":\"public\"}"],"content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"Pharmacogenomics knowledge for personalized medicine\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"ID\":{\"$\":\"22992668\",\"@Source\":\"PubMed\"}}},\"Citation\":{\"URL\":{\"$\":\"https://www.pharmgkb.org/clinicalAnnotation/981204929\"}},\"Interpretation\":{\"Citation\":[{\"ID\":{\"$\":\"15051775\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"19159907\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"20638924\",\"@Source\":\"PubMed\"}}],\"ExplanationOfInterpretation\":{\"$\":\"Drug-variant association: Toxicity/ADR\"}}}","local_key":"981204929PA449165|cyclophosphamide response - Toxicity/ADR","id":"SCV000268236","variation_archive_id":"VCV000003520","internal_id":"503703","version":"3","date_last_updated":"2019-03-31","assertion_type":"variation to disease","trait_set_id":"26869","review_status":"reviewed by expert panel","submission_names":["PharmGKB-ClinVar 2018-05"]}
{"date_created":"2017-03-03","rcv_accession_id":"RCV000428048","record_status":"current","interpretation_description":"Benign","submitter_id":"26957","clinical_assertion_observation_ids":["SCV000519504.0"],"variation_id":"3520","submitted_assembly":"GRCh37","interpretation_date_last_evaluated":"2016-04-25","submission_id":"26957.2018-03-26","clinical_assertion_trait_set_id":"SCV000519504","interpretation_comments":["{\"text\":\"This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease.\",\"type\":\"public\"}"],"content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"GeneDX Variant Classification (06012015)\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"URL\":{\"$\":\"https://submit.ncbi.nlm.nih.gov/ft/byid/7oynscmk/mdi-5616_26957_genedx_interprules_final_061215.pdf\"}}}}","local_key":"GDX:570299|Not Provided","id":"SCV000519504","variation_archive_id":"VCV000003520","internal_id":"984917","version":"4","date_last_updated":"2019-03-31","assertion_type":"variation to disease","trait_set_id":"9590","review_status":"criteria provided, single submitter","submission_names":["SUB3839901"]}
{"date_created":"2019-03-28","record_status":"current","interpretation_description":"Uncertain significance","submitter_id":"500105","clinical_assertion_observation_ids":["SCV000895101.0"],"variation_id":"37594","submitted_assembly":"GRCh37","interpretation_date_last_evaluated":"2018-10-31","submission_id":"500105.2018-11-14","clinical_assertion_trait_set_id":"SCV000895101","interpretation_comments":[],"content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"ACMG Guidelines, 2015\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"ID\":{\"$\":\"25741868\",\"@Source\":\"PubMed\"}}},\"Citation\":{\"@Abbrev\":\"ACMG, 2015\",\"@Type\":\"practice guideline\",\"ID\":[{\"$\":\"25741868\",\"@Source\":\"PubMed\"},{\"$\":\"10.1038/gim.2015.30\",\"@Source\":\"DOI\"}]}}","local_key":":Chr.17_41251893_41251893_T_G|OMIM:114480;604370;614320;617883","id":"SCV000895101","variation_archive_id":"VCV000037594","internal_id":"1751540","version":"1","date_last_updated":"2019-05-02","assertion_type":"variation to disease","review_status":"criteria provided, single submitter","submission_names":["SUB4786732"]}
{"date_created":"2016-03-15","record_status":"current","interpretation_description":"Uncertain significance","submitter_id":"505720","clinical_assertion_observation_ids":["SCV000265873.0"],"variation_id":"37594","submitted_assembly":"GRCh37","interpretation_date_last_evaluated":"2015-11-01","submission_id":"505720.2016-02-27","clinical_assertion_trait_set_id":"SCV000265873","interpretation_comments":[],"content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"ACMG Guidelines, 2015\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"ID\":{\"$\":\"25741868\",\"@Source\":\"PubMed\"}}},\"Citation\":[{\"@Type\":\"general\",\"ID\":{\"$\":\"27257965\",\"@Source\":\"PubMed\"}},{\"@Type\":\"general\",\"ID\":{\"$\":\"27257965\",\"@Source\":\"PubMed\"}}],\"Interpretation\":{\"Citation\":{\"@Type\":\"general\",\"ID\":{\"$\":\"27257965\",\"@Source\":\"PubMed\"}}}}","local_key":"NM_007294.3:c.446A\u003eC|MedGen:CN221572","id":"SCV000265873","variation_archive_id":"VCV000037594","internal_id":"498108","version":"1","date_last_updated":"2019-05-02","assertion_type":"variation to disease","review_status":"criteria provided, single submitter","submission_names":["Chinese507BC_BRCA"]}
{"date_created":"2018-04-04","rcv_accession_id":"RCV000039762","record_status":"current","interpretation_description":"Likely benign","submitter_id":"26957","clinical_assertion_observation_ids":["SCV000729392.0"],"variation_id":"46503","submitted_assembly":"GRCh37","interpretation_date_last_evaluated":"2017-11-21","submission_id":"26957.2018-03-26","clinical_assertion_trait_set_id":"SCV000729392","interpretation_comments":["{\"text\":\"This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease.\",\"type\":\"public\"}"],"content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"GeneDX Variant Classification (06012015)\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"URL\":{\"$\":\"https://submit.ncbi.nlm.nih.gov/ft/byid/7oynscmk/mdi-5616_26957_genedx_interprules_final_061215.pdf\"}}}}","local_key":"GDX:46979|Not Provided","id":"SCV000729392","variation_archive_id":"VCV000046503","internal_id":"1410550","version":"1","date_last_updated":"2019-03-31","assertion_type":"variation to disease","trait_set_id":"9590","review_status":"criteria provided, single submitter","submission_names":["SUB3839901"]}
{"date_created":"2018-03-28","rcv_accession_id":"RCV000727222","record_status":"current","interpretation_description":"Uncertain significance","submitter_id":"500060","clinical_assertion_observation_ids":["SCV000706730.0"],"variation_id":"46503","submitted_assembly":"GRCh37","interpretation_date_last_evaluated":"2018-05-30","submission_id":"500060.2018-09-19","clinical_assertion_trait_set_id":"SCV000706730","interpretation_comments":[],"content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"EGL_ClinVar_v180209_classification definitions\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"URL\":{\"$\":\"https://submit.ncbi.nlm.nih.gov/ft/byid/leconafi/egl_clinvar_v180209_classification_definitions.pdf\"}}},\"Citation\":{\"URL\":{\"$\":\"http://www.egl-eurofins.com/emvclass/emvclass.php?approved_symbol=PCDH15\"}},\"ClinVarSubmissionID\":{\"@localKeyIsSubmitted\":\"1\"}}","local_key":"60128_000000","id":"SCV000706730","variation_archive_id":"VCV000046503","internal_id":"1379128","version":"2","date_last_updated":"2019-03-31","assertion_type":"variation to disease","trait_set_id":"9460","review_status":"criteria provided, single submitter","submission_names":["SUB4534263"]}
{"date_created":"2018-03-28","rcv_accession_id":"RCV000726979","record_status":"current","interpretation_description":"Uncertain significance","submitter_id":"500060","clinical_assertion_observation_ids":["SCV000704632.0"],"variation_id":"48176","submitted_assembly":"GRCh37","interpretation_date_last_evaluated":"2016-12-20","submission_id":"500060.2018-09-19","clinical_assertion_trait_set_id":"SCV000704632","interpretation_comments":[],"content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"EGL_Classification_Definitions_2015\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"URL\":{\"$\":\"https://submit.ncbi.nlm.nih.gov/ft/byid/dn5yhybg/egl_classification_definitions_2015.pdf\"}}},\"Citation\":{\"URL\":{\"$\":\"http://www.egl-eurofins.com/emvclass/emvclass.php?approved_symbol=OTOF\"}},\"ClinVarSubmissionID\":{\"@localKeyIsSubmitted\":\"1\"}}","local_key":"57851_000000","id":"SCV000704632","variation_archive_id":"VCV000048176","internal_id":"1377031","version":"2","date_last_updated":"2019-03-31","assertion_type":"variation to disease","trait_set_id":"9460","review_status":"criteria provided, single submitter","submission_names":["SUB4534263"]}
{"date_created":"2014-02-18","rcv_accession_id":"RCV000078671","record_status":"current","interpretation_description":"not provided","submitter_id":"500304","clinical_assertion_observation_ids":["SCV000117933.0"],"variation_id":"7884","submission_id":"500304.2012-12-20","clinical_assertion_trait_set_id":"SCV000117933","interpretation_comments":[],"content":"{\"Comment\":{\"$\":\"http://phencode.bx.psu.edu/cgi-bin/phencode/phencode?build=hg19\u0026id=RISN_ABCR:c.6148G\u003eC\",\"@Type\":\"public\"}}","local_key":"RISN-ABCR:c.6148G\u003eC","id":"SCV000117933","variation_archive_id":"VCV000007884","internal_id":"205773","version":"1","date_last_updated":"2019-04-19","assertion_type":"variation to disease","trait_set_id":"9460","review_status":"no assertion provided","submission_names":["RISN_LSDB_112012"]}
{"date_created":"2017-09-07","rcv_accession_id":"RCV000504806","record_status":"current","interpretation_description":"Likely pathogenic","submitter_id":"505998","clinical_assertion_observation_ids":["SCV000599010.0"],"variation_id":"7884","submitted_assembly":"GRCh37","interpretation_date_last_evaluated":"2015-01-01","submission_id":"505998.2017-08-18","clinical_assertion_trait_set_id":"SCV000599010","interpretation_comments":[],"content":"{\"Citation\":{\"@Type\":\"general\",\"ID\":{\"$\":\"28041643\",\"@Source\":\"PubMed\"}},\"ClinVarSubmissionID\":{\"@localKeyIsSubmitted\":\"1\"},\"Interpretation\":{\"Citation\":{\"ID\":{\"$\":\"9054934\",\"@Source\":\"PubMed\"}}}}","local_key":"c.6148G\u003eC_HP:0000548","id":"SCV000599010","variation_archive_id":"VCV000007884","internal_id":"1160860","version":"1","date_last_updated":"2019-03-31","assertion_type":"variation to disease","trait_set_id":"33742","review_status":"no assertion criteria provided","submission_names":["NIHR_Bioresource_Rare_Diseases_Retinal_Dystrophy"]}
{"date_created":"2016-12-02","rcv_accession_id":"RCV000340261","record_status":"current","interpretation_description":"Likely benign","submitter_id":"504895","clinical_assertion_observation_ids":["SCV000359225.0"],"variation_id":"7884","submitted_assembly":"GRCh37","interpretation_date_last_evaluated":"2016-06-14","submission_id":"504895.2016-10-18","clinical_assertion_trait_set_id":"SCV000359225","interpretation_comments":[],"content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"ICSL Variant Classification 20161018\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"@Type\":\"general\",\"CitationText\":{\"$\":\"ICSL_Variant_Classification_20161018.pdf\"},\"URL\":{\"$\":\"https://submit.ncbi.nlm.nih.gov/ft/byid/4jQgNGYk/ICSL_Variant_Classification_20161018.pdf\"}}}}","local_key":"293398|Stargardt Disease, Recessive","id":"SCV000359225","variation_archive_id":"VCV000007884","internal_id":"672747","version":"2","date_last_updated":"2019-03-31","assertion_type":"variation to disease","trait_set_id":"33430","review_status":"criteria provided, single submitter","submission_names":["ICSL_2016Q4"]}
{"date_created":"2016-12-02","rcv_accession_id":"RCV000393715","record_status":"current","interpretation_description":"Likely benign","submitter_id":"504895","clinical_assertion_observation_ids":["SCV000359223.0"],"variation_id":"7884","submitted_assembly":"GRCh37","interpretation_date_last_evaluated":"2016-06-14","submission_id":"504895.2016-10-18","clinical_assertion_trait_set_id":"SCV000359223","interpretation_comments":[],"content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"ICSL Variant Classification 20161018\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"@Type\":\"general\",\"CitationText\":{\"$\":\"ICSL_Variant_Classification_20161018.pdf\"},\"URL\":{\"$\":\"https://submit.ncbi.nlm.nih.gov/ft/byid/4jQgNGYk/ICSL_Variant_Classification_20161018.pdf\"}}}}","local_key":"293398|Retinitis Pigmentosa, Recessive","id":"SCV000359223","variation_archive_id":"VCV000007884","internal_id":"672745","version":"2","date_last_updated":"2019-03-31","assertion_type":"variation to disease","trait_set_id":"33382","review_status":"criteria provided, single submitter","submission_names":["ICSL_2016Q4"]}
{"date_created":"2016-12-02","rcv_accession_id":"RCV000393726","record_status":"current","interpretation_description":"Likely benign","submitter_id":"504895","clinical_assertion_observation_ids":["SCV000359226.0"],"variation_id":"7884","submitted_assembly":"GRCh37","interpretation_date_last_evaluated":"2016-06-14","submission_id":"504895.2016-10-18","clinical_assertion_trait_set_id":"SCV000359226","interpretation_comments":[],"content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"ICSL Variant Classification 20161018\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"@Type\":\"general\",\"CitationText\":{\"$\":\"ICSL_Variant_Classification_20161018.pdf\"},\"URL\":{\"$\":\"https://submit.ncbi.nlm.nih.gov/ft/byid/4jQgNGYk/ICSL_Variant_Classification_20161018.pdf\"}}}}","local_key":"293398|Macular Degeneration","id":"SCV000359226","variation_archive_id":"VCV000007884","internal_id":"672748","version":"2","date_last_updated":"2019-03-31","assertion_type":"variation to disease","trait_set_id":"33398","review_status":"criteria provided, single submitter","submission_names":["ICSL_2016Q4"]}
{"date_created":"2016-06-16","rcv_accession_id":"RCV000008335","record_status":"current","interpretation_description":"Likely pathogenic","submitter_id":"505832","clinical_assertion_observation_ids":["SCV000281950.0"],"variation_id":"7884","submitted_assembly":"GRCh37","interpretation_date_last_evaluated":"2016-01-01","submission_id":"505832.2016-05-25","clinical_assertion_trait_set_id":"SCV000281950","interpretation_comments":[],"content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"Schulz et al. (Invest Ophthalmol Vis Sci. 2017)\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"@Type\":\"general\",\"ID\":{\"$\":\"28118664\",\"@Source\":\"PubMed\"}}},\"Citation\":[{\"@Type\":\"general\",\"ID\":{\"$\":\"28118664\",\"@Source\":\"PubMed\"}},{\"@Type\":\"general\",\"ID\":{\"$\":\"28118664\",\"@Source\":\"PubMed\"}}],\"ClinVarSubmissionID\":{\"@localKeyIsSubmitted\":\"1\"},\"Interpretation\":{\"Citation\":[{\"ID\":{\"$\":\"9054934\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"23940504\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"20335603\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"16103129\",\"@Source\":\"PubMed\"}},{\"@Type\":\"general\",\"ID\":{\"$\":\"28118664\",\"@Source\":\"PubMed\"}}]}}","local_key":"162","id":"SCV000281950","variation_archive_id":"VCV000007884","internal_id":"533093","version":"2","date_last_updated":"2019-03-31","assertion_type":"variation to disease","trait_set_id":"1448","review_status":"criteria provided, single submitter","submission_names":["STGD2016"]}
{"date_created":"2017-03-03","rcv_accession_id":"RCV000078671","record_status":"current","interpretation_description":"Uncertain significance","submitter_id":"26957","clinical_assertion_observation_ids":["SCV000511911.0"],"variation_id":"7884","submitted_assembly":"GRCh37","interpretation_date_last_evaluated":"2018-11-07","submission_id":"26957.2019-01-29","clinical_assertion_trait_set_id":"SCV000511911","interpretation_comments":["{\"text\":\"The V2050L variant in the ABCA4 gene has been reported previously in association with Stargardt disease, macular dystrophy, cone-rod dystrophy, and age-related macular degeneration (Lewis et al., 1999; Wiszniewski et al., 2005; Poloschek et al., 2010; Fritsche et al., 2012; Corton et al., 2013). Poloschek et al. (2010) reported that V2050L heterozygous carriers show centrally reduced mfERG amplitudes and additional minor fundus abnormalities, which suggested that the V2050L variant in the heterozygous state is capable of mildly reducing macular function without an additional pathogenic variant on the second allele. However, the V2050L variant is observed in 202/34420 (0.5869%) alleles from individuals of Latino background and 787/277174 (0.2839%) global alleles, with one homozygote reported (Lek et al., 2016). The V2050L variant is a conservative amino acid substitution, which occurs at a position that is conserved across species. In-silico analyses, including protein predictors and evolutionary conservation, support that this variant does not alter protein structure/function. We interpret V2050L as a variant of uncertain significance.\",\"type\":\"public\"}"],"content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"GeneDx Variant Classification (06012015)\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"URL\":{\"$\":\"https://submit.ncbi.nlm.nih.gov/ft/byid/7oynscmk/mdi-5616_26957_genedx_interprules_final_061215.pdf\"}}}}","local_key":"GDX:874|Not Provided","id":"SCV000511911","variation_archive_id":"VCV000007884","internal_id":"977225","version":"3","date_last_updated":"2019-05-09","assertion_type":"variation to disease","trait_set_id":"9460","review_status":"criteria provided, single submitter","submission_names":["SUB5098196"]}
